News
-
-
-
-
PRESS RELEASE
Amoéba receives its first order from Koppert and confirms its transformation into a commercial company
Amoéba announces its first order from partner Koppert, marking a new phase in its history. The biocontrol business is now structured around subsidiary Green 4 Agro, headed by Jean-Marc PETAT -
-
-
-
-
PRESS RELEASE
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG
Results of the 2026 Annual General Meeting for the 2024/25 financial year of BRAIN Biotech AG. Shareholders approve all agenda items. New member elected to the Supervisory Board. CEO highlights company's strategy and unique selling points -
PRESS RELEASE
ParTec and BF exaQC Take Note of Largely Favorable but Dismissive First-Instance Ruling. A Pyrrhic Victory for NVIDIA?!
ParTec and BF exaQC take note of largely favorable but dismissive ruling by the European Unified Patent Court confirming NVIDIA's use of patented architecture. Appeal planned